Associate Professor, Department of Medicine (Cardiology), Icahn School of Medicine at Mount Sinai
Kevin D. Costa is Associate Professor of Medicine (Cardiology) at the Icahn School of Medicine at Mount Sinai in New York City. Dr. Costa earned B.S. and M.S. degrees in Biomedical Engineering from Boston University in 1988 and 1990, and the Ph.D. in Bioengineering from the University of California, San Diego in 1996. Following postdoctoral fellowships at The Johns Hopkins University and Washington University in St. Louis, Dr. Costa joined the faculty at Columbia University from 1999 to 2008, where he was Associate Professor of Biomedical Engineering and co-Director of the Cardiac Biomechanics Group. In 2009 he was recruited to the Cardiovascular Research Center at Mount Sinai to direct a research program in Cardiovascular Cell and Tissue Engineering.
Research in the Costa Laboratory is focused on the multi-scale biomechanics and mechanobiology of cardiovascular remodeling, injury, repair, and regeneration using state-of-the-art techniques including atomic force microscopy (AFM), nanomedicine, computational modeling, and 3D tissue and organoid engineering. An emphasis on human-specific cell sources helps to ensure clinical relevance for the translational aspects of this research.
Such translation often requires technology development and commercialization. With this goal, Dr. Costa co-founded Novoheart, Ltd., a publicly traded, global stem cell biotechnology company dedicated to revolutionizing the drug development process using engineering bioartificial human heart prototypes. Dr. Costa serves as Chief Scientific Officer for Novoheart.